Patents Assigned to Bioalternatives SAS
  • Patent number: 10080779
    Abstract: The invention disclosed herein relates to the field of epidermal repair and skin innate immunity. More particularly, the invention concerns the use of a mix of cytokines to inhibit keratinocyte differentiation, activate skin innate immunity, increase the expression of anti-microbial peptides, and improve epidermal repair. In particular, the invention concerns compositions comprising at least IL-17, TNF? and OSM that can be formulated for topical administration for cosmetic or dermatologic use.
    Type: Grant
    Filed: September 29, 2014
    Date of Patent: September 25, 2018
    Assignees: Universite D'Angers, Universite de Poitiers, Bioalternatives SAS
    Inventors: Jean-Claude Lecron, Hughes Gascan, Franck Morel, Sylvie Chevalier, Francois-Xavier Bernard, Katia Boniface, Caroline Diveau
  • Patent number: 7901669
    Abstract: The present invention relates to the field of epidermal repair. More particularly, the invention concerns the use of a molecule able to activate a heteromeric receptor comprising OSMR? as a subunit, for the preparation of a composition for activating in vitro and/or in vivo keratinocyte migration and/or the expression of anti-microbial peptides by the keratinocytes. In particular, the invention concerns the use of OSM and/or IL-17 and/or TNF? and/or IL-31, or agonists thereof, for the preparation of cosmetic or dermatologic compositions.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: March 8, 2011
    Assignees: Universite d'Angers, Universite de Poitiers, Bioalternatives SAS
    Inventors: Jean-Claude Lecron, Hughes Gascan, Franck Morel, Sylvie Chevalier, François-Xavier Bernard, Katia Boniface, Caroline Diveu